Immage Biotherapeutics Corp.
Immage Biotherapeutics Corp. (IMMG) Revenue
Annual & quarterly revenue history · segment & region breakdown
IMMG · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsImmage Biotherapeutics Corp. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2016.
Revenue trend
2016 – 2012 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2016-08-31 | $0.00B | +$0.00B | — |
| 2015-08-31 | $0.00B | +$0.00B | — |
| 2014-09-30 | $0.00B | +$0.00B | — |
| 2013-09-30 | $0.00B | +$0.00B | — |
| 2012-09-30 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Immage Biotherapeutics Corp. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Immage Biotherapeutics Corp. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Immage Biotherapeutics Corp.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
IMMG revenue · 4 questionsIMMG's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2016.
▸ Source: FMP · Immage Biotherapeutics Corp. SEC filings · GAAP · Immage Biotherapeutics Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026